Sandra J. Ginsberg

1.2k total citations
38 papers, 931 citations indexed

About

Sandra J. Ginsberg is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sandra J. Ginsberg has authored 38 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 9 papers in Pathology and Forensic Medicine and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sandra J. Ginsberg's work include Lung Cancer Research Studies (10 papers), Cancer Treatment and Pharmacology (8 papers) and Neuroendocrine Tumor Research Advances (7 papers). Sandra J. Ginsberg is often cited by papers focused on Lung Cancer Research Studies (10 papers), Cancer Treatment and Pharmacology (8 papers) and Neuroendocrine Tumor Research Advances (7 papers). Sandra J. Ginsberg collaborates with scholars based in United States, Germany and Canada. Sandra J. Ginsberg's co-authors include Robert L. Comis, John A. Meyer, Phillip M. Ikins, Frederick B. Parker, William A. Burke, Myron Miller, Santo M. DiFino, Vivian Weinberg, J F Holland and John J. Gullo and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Cancer.

In The Last Decade

Sandra J. Ginsberg

38 papers receiving 827 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra J. Ginsberg United States 18 531 316 244 117 115 38 931
J. Wendall Goodwin United States 16 522 1.0× 334 1.1× 221 0.9× 164 1.4× 186 1.6× 34 1.0k
S Krauß United States 17 678 1.3× 423 1.3× 360 1.5× 99 0.8× 233 2.0× 45 1.1k
Hwee‐Yong Yap United States 18 765 1.4× 398 1.3× 165 0.7× 99 0.8× 204 1.8× 31 1.3k
Charles K. Tashima United States 19 572 1.1× 385 1.2× 117 0.5× 158 1.4× 98 0.9× 54 1.1k
Joseph R. Bateman United States 19 534 1.0× 182 0.6× 132 0.5× 165 1.4× 177 1.5× 37 993
V.J. Harvey New Zealand 11 319 0.6× 176 0.6× 103 0.4× 127 1.1× 226 2.0× 24 678
Luciano Canobbio Italy 19 512 1.0× 190 0.6× 117 0.5× 151 1.3× 165 1.4× 53 812
Eugenio Villa Italy 14 676 1.3× 396 1.3× 114 0.5× 103 0.9× 215 1.9× 20 973
Jonathan C. Yau United States 17 454 0.9× 197 0.6× 105 0.4× 73 0.6× 128 1.1× 33 768
J Chauvergne France 16 353 0.7× 208 0.7× 107 0.4× 219 1.9× 121 1.1× 107 833

Countries citing papers authored by Sandra J. Ginsberg

Since Specialization
Citations

This map shows the geographic impact of Sandra J. Ginsberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra J. Ginsberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra J. Ginsberg more than expected).

Fields of papers citing papers by Sandra J. Ginsberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra J. Ginsberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra J. Ginsberg. The network helps show where Sandra J. Ginsberg may publish in the future.

Co-authorship network of co-authors of Sandra J. Ginsberg

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra J. Ginsberg. A scholar is included among the top collaborators of Sandra J. Ginsberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra J. Ginsberg. Sandra J. Ginsberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Newman, Nancy, Sandra J. Ginsberg, Arthur C. Louie, et al.. (1989). Phase II Study of Iproplatin (CHIP) in Previously Treated Small-Cell Lung Cancer. American Journal of Clinical Oncology. 12(4). 355–357. 6 indexed citations
3.
Ginsberg, Sandra J., et al.. (1989). A Phase II Trial of Iproplatin (CHIP) in Previously Treated Advanced Breast Cancer. American Journal of Clinical Oncology. 12(2). 129–131. 12 indexed citations
4.
Newman, Nancy, et al.. (1988). Phase II Trial of Iproplatin (CHIP) in Previously Untreated Patients with Colorectal Cancer. American Journal of Clinical Oncology. 11(6). 650–651. 4 indexed citations
5.
Gaver, Robert C., Bernard J. Poiesz, Arthur C. Louie, et al.. (1988). Phase I — Preliminary phase II trial of iproplatin, a cisplatin analogue. Investigational New Drugs. 6(3). 199–206. 7 indexed citations
6.
7.
Lachant, Neil A., James R. Anderson, Sandra J. Ginsberg, et al.. (1988). Treatment of refractory lymphoma with methotrexate, VM‐26 (teniposide), procarbazine, and dexamethasone: Cancer and leukemia group B study 7902. Medical and Pediatric Oncology. 16(6). 375–377. 2 indexed citations
8.
Perry, Michael C., Carl G. Kardinal, Ann H. Korzun, et al.. (1987). Chemohormonal therapy in advanced carcinoma of the breast: Cancer and Leukemia Group B protocol 8081.. Journal of Clinical Oncology. 5(10). 1534–1545. 25 indexed citations
9.
Ginsberg, Sandra J., Arlan J. Gottlieb, C. D. Bloomfield, et al.. (1987). A randomized trial of high-dose methotrexate versus standard-dose methotrexate following cyclophosphamide, doxorubicin (adriamycin), vincristine, and prednisone with or without bleomycin in the therapy of diffuse large cell lymphoma: preliminary report of Cancer and Leukemia Group B Study 7851.. PubMed. 77–80. 10 indexed citations
10.
Kardinal, Carl G., Michael C. Perry, Vivian Weinberg, et al.. (1983). Chemoendocrine therapy vs chemotherapy alone for advanced breast cancer in postmenopausal women: Preliminary report of a randomized study. Breast Cancer Research and Treatment. 3(4). 365–371. 21 indexed citations
11.
Meyer, John A., Robert L. Comis, Sandra J. Ginsberg, et al.. (1982). Phase II trial of extended indications for resection in small cell carcinoma of the lung. Journal of Thoracic and Cardiovascular Surgery. 83(1). 12–17. 45 indexed citations
12.
Ginsberg, Sandra J., Robert L. Comis, & Myron Miller. (1982). The development of hyponatremia following combination chemotherapy for metastatic germ cell tumors. Medical and Pediatric Oncology. 10(1). 7–14. 5 indexed citations
13.
Rl, Comis, et al.. (1981). Phase I trial of chlorozotocin: attempted amelioration of myelotoxicity by glucose administration.. PubMed. 65(7-8). 647–50. 3 indexed citations
14.
Ginsberg, Sandra J., et al.. (1981). Systemic chemotherapy for a primary germ cell tumor of the brain: a pharmacokinetic study.. PubMed. 65(5-6). 477–83. 54 indexed citations
15.
Kirshner, Jeffrey J., et al.. (1981). Treatment of a primary intracranial germ cell tumor with systemic chemotherapy. Medical and Pediatric Oncology. 9(4). 361–365. 15 indexed citations
16.
Comis, Robert L., Myron Miller, & Sandra J. Ginsberg. (1980). Abnormalities in water homeostasis in small cell anaplastic lung cancer. Cancer. 45(9). 2414–2421. 44 indexed citations
17.
Comis, Robert L., Thomas W. Griffin, Vic Raso, & Sandra J. Ginsberg. (1979). Pharmacokinetics of the protein antitumor antibiotic neocarzinostatin after bolus injection in humans.. PubMed. 39(3). 757–61. 7 indexed citations
18.
Ginsberg, Sandra J., A. Gottlieb, Jack Goldberg, et al.. (1979). Long-term survivorship in small-cell anaplastic lung carcinoma.. PubMed. 63(8). 1347–9. 28 indexed citations
19.
Meyer, John A., Robert L. Comis, Sandra J. Ginsberg, et al.. (1979). Selective surgical resection in small cell carcinoma of the lung. Journal of Thoracic and Cardiovascular Surgery. 77(2). 243–248. 36 indexed citations
20.
Ginsberg, Sandra J., Robert L. Comis, & Meredith Miller. (1978). Syndrome of inappropriate antidiuretic hormone secretion in oat cell carcinoma of the lung. Clinical research. 26(3). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Wendall Goodwin Breakdown of academic impact, for papers by S Krauß Breakdown of academic impact, for papers by Hwee‐Yong Yap Breakdown of academic impact, for papers by Charles K. Tashima Breakdown of academic impact, for papers by Joseph R. Bateman Breakdown of academic impact, for papers by V.J. Harvey Breakdown of academic impact, for papers by Luciano Canobbio Breakdown of academic impact, for papers by Eugenio Villa Breakdown of academic impact, for papers by Jonathan C. Yau Breakdown of academic impact, for papers by J Chauvergne
Rankless by CCL
2026